Mayo Clinic Cancer Center

Phoenix, Arizona 85054

2 studies enrolling now · 21 studies all time

What they study most

Advanced Renal Cell Carcinoma, Bladder Cancer, Cancer of the Bladder, Recurrent, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Extrahepatic, Cholangiocarcinoma, Intrahepatic, Cholangiocarcinoma, Perihilar, Chronic Graft Versus Host Disease, Chronic Lymphocytic Leukemia, Conventional Chondrosarcoma, GIST

Studies at this site

• IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) — Recruiting now
• A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) — Recruiting now
• Study of INBRX-109 in Conventional Chondrosarcoma — Running, not enrolling
• Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin — Running, not enrolling
• CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer — Running, not enrolling
• A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer — Stopped early
• Financial Difficulty in Patients With Blood Cancer — Completed
• Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer — Running, not enrolling
• JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations — Paused
• A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma — Completed
• INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma — Completed
• Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a KRAS Mutation — Completed
• CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma — Completed
• Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer — Stopped early
• Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease — Completed
• (VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST — Completed
• A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer — Completed
• A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma — Completed
• A Phase 2 Study of RO7490677 In Participants With Myelofibrosis — Completed
• Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer — Status unconfirmed
• Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study — Completed